soul trial oral semaglutide cardiovascular outcomes 2024 nejm results 🚨 25 mg delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - 🧿 Oral semaglutide is the

24+ Months: Long-Term Maintenance Decision At this point, patients and their physician make a shared decision: attempt a carefully managed tapering and transition to maintenance, or continue long-term medication for ongoing metabolic management

When comparing treatment options, Semaglutides well-documented track record offers confidence for those beginning their weight management journey

Here is how it works : GLP-1 is released: Glucagon-like peptide-1 (GLP-1), a hormone produced in the intestinal endocrine cells, is released when you eat

Thus, the conclusions of those studies must be further validated, and a wider range of studies is necessary to ensure the reliability of the findings